Prices of chemically modified Plavix to fall

Published: 2008-06-03 06:58:00

Updated: 2008-06-03 06:58:00

There is mounting discomfort among six domestic producers of chemically modified Plavix, anticlotting medicine, that the prices of their products will be decreased by lower than 68 percent over the original drug.

These drug makers include Kwangdong Pharm, Hanlim Pharm, Reyon, Colma Korea and H...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK